Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients.

Lee CT, Chua S, Hsu CY, Tsai YC, Ng HY, Kuo CC, Wu CH, Chen TC, Chiu TT, Lee YT.

Dis Markers. 2013;34(4):229-35. doi: 10.3233/DMA-130965.

2.

Vascular calcification in Mexican hemodialysis patients.

Rojas-Campos E, Herrera-Llamas R, Montañez-Fernández JL, Martínez-Martínez P, Andrade-Sierra J, Avila-Baray AA, Cueto-Manzano AM.

Arch Med Res. 2013 Nov;44(8):628-32. doi: 10.1016/j.arcmed.2013.10.018. Epub 2013 Nov 8.

PMID:
24211752
3.

A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.

Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrao AP.

Nephrol Dial Transplant. 2004 Jun;19(6):1480-8. Epub 2004 Mar 19.

PMID:
15034154
4.

Clinical features of hemodialysis patients with intimal versus medial vascular calcifications.

Damjanovic T, Djuric S, Schlieper G, Markovic N, Dimkovic S, Radojicic Z, Krüger T, Floege J, Dimkovic N.

J Nephrol. 2009 May-Jun;22(3):358-66.

PMID:
19557712
5.

Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients.

Moldovan D, Kacso IM, Rusu C, Potra A, Bondor CI, Moldovan I, Patiu IM, Vladutiu D, Caprioara MG.

Biomarkers. 2015 Mar;20(2):116-22. doi: 10.3109/1354750X.2014.1000376. Epub 2015 Jan 14.

PMID:
25585925
6.

Factors associated with various arterial calcifications in haemodialysis patients.

Gelev S, Spasovski G, Trajkovski Z, Damjanovski G, Amitov V, Selim G, Dzekova P, Sikole A.

Prilozi. 2008 Dec;29(2):185-199.

PMID:
19259046
7.

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remédio F, Ribeiro F.

Nephrol Dial Transplant. 1998 Aug;13(8):2037-40.

PMID:
9719161
9.

Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice?

Gelev S, Spasovski G, Dzikova S, Trajkovski Z, Damjanovski G, Amitov V, Sikole A.

Int Urol Nephrol. 2008;40(3):763-70. doi: 10.1007/s11255-008-9379-y. Epub 2008 Jun 27.

PMID:
18584302
10.

Screening of vascular calcifications in patients with end-stage renal diseases.

Damjanovic T, Djuric Z, Markovic N, Dimkovic S, Radojicic Z, Dimkovic N.

Gen Physiol Biophys. 2009;28 Spec No:277-83.

12.

Impact of lower limbs' arterial calcification on the prevalence and severity of PAD in patients on hemodialysis.

Ohtake T, Oka M, Ikee R, Mochida Y, Ishioka K, Moriya H, Hidaka S, Kobayashi S.

J Vasc Surg. 2011 Mar;53(3):676-83. doi: 10.1016/j.jvs.2010.09.070. Epub 2011 Jan 6.

13.

Arterial micro-calcification of vascular access is associated with aortic arch calcification and arterial stiffness in hemodialysis patients.

Kim HG, Park SC, Lee SL, Shin OR, Yoon SA, Yang CW, Kim Y, Kim YO.

Semin Dial. 2013 Mar-Apr;26(2):216-22. doi: 10.1111/j.1525-139X.2012.01113.x. Epub 2012 Aug 22.

14.

Prevalence and risk factors of valvular calcification in hemodialysis patients.

Sayarlioglu H, Acar G, Sahin M, Altunoren O, Coskun Yavuz Y, Nacar AB, Dogan E.

Iran J Kidney Dis. 2013 Mar;7(2):129-34.

15.

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.

Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE.

Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. Epub 2005 May 17.

PMID:
15899935
16.

Valvular calcification, inflammation, and mortality in dialysis patients.

Mohamed BA, Yang W, Litt H, Rosas SE.

J Heart Valve Dis. 2013 Jul;22(4):584-90.

PMID:
24224425
17.

Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.

Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A.

Clin J Am Soc Nephrol. 2012 Jun;7(6):965-73. doi: 10.2215/CJN.11191111. Epub 2012 Apr 5.

18.

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H.

Nephrol Dial Transplant. 2003 Sep;18(9):1731-40.

PMID:
12937218
19.

Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.

An WS, Kim SE, Kim KH, Bae HR, Rha SH.

J Korean Med Sci. 2009 Jan;24 Suppl:S115-20. doi: 10.3346/jkms.2009.24.S1.S115. Epub 2009 Jan 28.

20.

Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients.

Nishiura R, Fujimoto S, Sato Y, Yamada K, Hisanaga S, Hara S, Nakao H, Kitamura K.

Am J Nephrol. 2009;29(3):257-63. doi: 10.1159/000157629. Epub 2008 Sep 19.

PMID:
18802328

Supplemental Content

Support Center